Altimmune, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Altimmune, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Altimmune, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 71.1M shares, a 34.6% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 71.1M +18.3M +34.6% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 71M +18.4M +34.9% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 70.9M +21.6M +43.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 70.7M +21.5M +43.7% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 52.9M +3.7M +7.52% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 52.7M +6.29M +13.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 49.3M +6.07M +14% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 49.2M +8.21M +20% Dec 31, 2022 10-K 2024-03-27
Q3 2022 49.2M +9.46M +23.8% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 46.4M +6.68M +16.8% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 43.2M +4.96M +13% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 41M +3.85M +10.4% Dec 31, 2021 10-K 2023-02-28
Q3 2021 39.7M +6.63M +20% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 39.7M +13.1M +49.5% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 38.3M +22.9M +149% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 37.1M +21.8M +143% Dec 31, 2020 10-K 2022-03-15
Q3 2020 33.1M +17.7M +116% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 26.6M +13.1M +97.4% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 15.4M +1.91M +14.2% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 15.3M +6.23M +68.7% Dec 31, 2019 10-K 2021-02-25
Q3 2019 15.3M +13.6M +789% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 13.5M -23.9M -64% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 13.5M -8.82M -39.6% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 9.08M +8.47M +1390% Dec 31, 2018 10-K 2020-03-27
Q3 2018 1.73M -13.9M -89% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 37.4M +21.9M +142% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 22.3M -46.5M -67.6% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 609K -6.38M -91.3% Dec 31, 2017 10-K 2019-04-01
Q3 2017 15.7M -50.8M -76.4% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 15.5M -49.3M -76.1% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 68.8M +4.37M +6.78% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 6.99M -57.4M -89.1% Dec 31, 2016 10-K 2018-04-02
Q3 2016 66.4M +2.06M +3.21% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 64.8M +874K +1.37% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 64.4M +770K +1.21% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 64.4M +779K +1.22% Dec 31, 2015 10-K 2017-03-14
Q3 2015 64.4M +2.14M +3.44% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 63.9M +8.39M +15.1% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 63.7M +9.9M +18.4% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 63.6M +11.3M +21.6% Dec 31, 2014 10-K 2016-03-11
Q3 2014 62.2M +9.92M +19% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 55.5M +4.35M +8.5% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 53.8M +5.36M +11.1% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 52.3M +3.95M +8.17% Dec 31, 2013 10-K 2015-03-11
Q3 2013 52.3M +3.95M +8.17% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 51.2M +2.83M +5.85% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 48.4M +102K +0.21% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 48.4M +116K +0.24% Dec 31, 2012 10-K 2014-03-11
Q3 2012 48.3M +152K +0.32% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 48.3M +152K +0.32% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 48.3M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 48.2M +2M +4.32% Dec 31, 2011 10-K 2013-03-14
Q3 2011 48.2M Sep 30, 2011 10-Q 2011-11-09
Q2 2011 48.2M Jun 30, 2011 10-Q 2011-08-11
Q4 2010 46.2M Dec 31, 2010 10-K 2012-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.